Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Molecular Ecology|October 20, 2007
Microsatellite variation points to local landscape plantings as sources of invasive pampas grass (Cortaderia selloana) in CaliforniaMiki Okada, Riaz Ahmad, Marie Jasieniuk
Biochemical and Biophysical Research Communications|April 12, 2002
Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 proteinMiki Okada, Hiroshi Tokumitsu, Yasuo Kubota, et al.
Endocrine Journal|September 13, 2021
Elucidating exercise-induced skeletal muscle signaling pathways and applying relevant findings to preemptive therapy for lifestyle-related diseasesMasato Iwabu, Miki Okada-Iwabu, Takashi Kadowaki, et al.
Frontiers in Cardiovascular Medicine|September 3, 2019
Adiponectin/AdipoR Research and Its Implications for Lifestyle-Related DiseasesMasato Iwabu, Miki Okada-Iwabu, Toshimasa Yamauchi, et al.
Molecular Ecology|February 5, 2015
The role of climate adaptation in colonization success in Arabidopsis thalianaJill A Hamilton, Miki Okada, Tonia Korves, et al.
NPJ Aging and Mechanisms of Disease|July 20, 2017
Adiponectin/adiponectin receptor in disease and agingMasato Iwabu, Miki Okada-Iwabu, Toshimasa Yamauchi, et al.
Diabetology International|October 9, 2019
Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevityMiki Okada-Iwabu, Masato Iwabu, Toshimasa Yamauchi, et al.
Clinical Calcium|June 27, 2017
[Aging and homeostasis. Development of novel AdipoR-targeted drugs with exercise-mimicking and anti-aging properties.]Miki Okada-Iwabu, Toshimasa Yamauchi, Masato Iwabu, et al.
International Journal of Molecular Sciences|April 17, 2025
Recent Progress in N-Acylethanolamine Research: Biological Functions and Metabolism Regulated by Two Distinct N-Acyltransferases: cPLA2ε and PLAAT EnzymesToru Uyama, Sumire Sasaki, Miki Okada-Iwabu, et al.
Clinical Calcium|March 1, 2016
[Adiponectin receptor-targeted therapy for lifestyle-related diseases]Masato Iwabu, Toshimasa Yamauchi, Miki Okada-Iwabu, et al.
Pageof 6